Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

DYNDYN
Showing 7 of 23 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in DYNE THERAPEUTICS INC

Yes. Janus Henderson holds 13,647,376 shares of DYN (Dyne Therapeutics), worth $247.4M, as of its Q1 2026 13F filing. It reduced the position by 240,346 shares (-1.7%) from Q4 2025. Janus Henderson has held DYN since Q1 2023, across 13 quarterly 13F filings. DYN is 0.1% of Janus Henderson's reported 13F portfolio.

Current Value

$247.4M

Current Shares

13.6M

Total Value Change

+$2.7M

Total Shares Change

+6.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
13.6M
-1.7%
$247.4M0.1%$14.60
0
2025-Q4
Decreased
13.9M
-5.8%
$271.6M0.1%$19.20
0
2025-Q3
Increased
14.7M
+56.2%
$186.5M0.1%$12.37
43
2025-Q2
Decreased
9.4M
-8.8%
$89.9M0.0%$9.57
0
2025-Q1
Increased
10.4M
+40.3%
$118.5M0.1%$11.45
40
2024-Q4
Increased
7.4M
+8.3%
$173.8M0.1%$23.65
33
2024-Q3
Increased
6.8M
+47.4%
$244.8M0.1%$33.83
50

Other major holders of DYN: FMR LLC, BlackRock, Inc., Jupiter Topco LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used